Disposable bioprocessing systems / / Sarfaraz K. Niazi.

Because of many misconceptions, the biological drug manufacturing industry does not fully utilize disposable components, despite their wide availability. These misconceptions include concerns for the quality of materials, running costs, scalability, the level of automation possible, and the training...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
Place / Publishing House:Boca Raton, Fla. : : CRC Press,, 2012.
Year of Publication:2012
Language:English
Physical Description:1 online resource (314 p.)
Notes:Description based upon print version of record.
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 01222cam a2200241Ii 4500
001 993547475804498
005 20210210000558.0
006 m o d |
007 cr -n---------
008 180331s2012 flua ob 001 0 eng d
020 |a 1-000-21874-0 
020 |a 0-429-10496-0 
020 |a 1-280-12257-9 
020 |a 9786613526434 
020 |a 1-4398-6695-3 
024 7 |a 10.1201/b11472   |2 doi 
035 |a (CKB)2550000000073317 
035 |a (EBL)826971 
035 |a (SSID)ssj0000580997 
035 |a (PQKBManifestationID)11392974 
035 |a (PQKBTitleCode)TC0000580997 
035 |a (PQKBWorkID)10525115 
035 |a (PQKB)11171760 
035 |a (MiAaPQ)EBC826971 
035 |a (MiAaPQ)EBC4010059 
035 |a (OCoLC)781261820 
035 |a (Au-PeEL)EBL4010059 
035 |a (OCoLC)958539172 
035 |a (EXLCZ)992550000000073317 
040 |a MiAaPQ  |c MiAaPQ  |d MiAaPQ 
041 |a eng 
050 4 |a TP248.3  |b .N53 2012 
082 0 0 |a 615.19 
100 1 |a Niazi, Sarfaraz K.,  |e author. 
245 1 0 |a Disposable bioprocessing systems /  |c Sarfaraz K. Niazi. 
264 1 |a Boca Raton, Fla. :  |b CRC Press,  |c 2012. 
300 |a 1 online resource (314 p.) 
336 |a text  |b txt 
337 |a computer  |b c 
338 |a online resource  |b cr 
500 |a Description based upon print version of record. 
505 0 |a Front Cover; Contents; Disclaimer; Preface; Author; Chapter 1: The Bioprocessing Industry-An Introduction; Chapter 2: Safety of Disposable Systems; Chapter 3: Containers; Chapter 4: Mixing Systems; Chapter 5: Disposable Bioreactors; Chapter 6: Connectors and Transfers; Chapter 7: Controls; Chapter 8: Downstream Processing; Chapter 9: Filling and Finishing Systems; Chapter 10: Filtration; Chapter 11: Regulatory Compliance; Chapter 12: Environmental Concerns; Chapter 13: Epilogue; Bibliography; Back Cover 
520 |a Because of many misconceptions, the biological drug manufacturing industry does not fully utilize disposable components, despite their wide availability. These misconceptions include concerns for the quality of materials, running costs, scalability, the level of automation possible, and the training of staff needed to include these components in existing bioprocessing systems. Not fully realizing the long-term benefits, many manufacturers are unwilling to discard investments made in fixed equipment and traditional stainless steel systems. Regulatory and environmental concerns, however, will ev 
546 |a English 
504 |a Includes bibliographical references. 
588 |a Description based on publisher supplied metadata and other sources. 
650 0 |a Biochemical engineering. 
655 4 |a Electronic books. 
776 |z 1-4398-6670-8 
906 |a BOOK 
ADM |b 2022-07-20 11:44:32 Europe/Vienna  |f System  |c marc21  |a 2012-02-26 02:13:27 Europe/Vienna  |g false 
AVE |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338545260004498&Force_direct=true  |Z 5338545260004498  |8 5338545260004498